Eikonoklastes Therapeutics, Inc. vs Spur Therapeutics
Spur Therapeutics
Toward the next generation of gene therapy
122 employees · est. 2015 · Stevenage, United Kingdom
Spur Therapeutics is the older company (2019 vs 2015); Spur Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Eikonoklastes Therapeutics, Inc. | Spur Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2015 older |
| Headquarters | ||
| Headquarters | Not tracked yet | Stevenage, United Kingdom |
| Employees | ||
| Employees | 8 | 122 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Life Sciences | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series A | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $5.98M | $260.50M |
| Funding Rounds | ||
| Funding Rounds | 2 | 7 |
| Taxonomy | ||
| Taxonomy | BiopharmaceuticalNeurodegenerative DiseasesGene TherapyALSLou Gehrig’s DiseaseNerve Disease +8 | Gene TherapyLiver-directedInherited DiseasesClinical TrialsAAV-based TherapyHemophilia B +8 |
| Website | ||
| Website | eikonoklastes.com | spurtherapeutics.com |
About Eikonoklastes Therapeutics, Inc.
Eikonoklastes Therapeutics, Inc. is an early-stage biopharmaceutical company that is striving to revolutionize the treatment of neurodegenerative diseases. The company's groundbreaking gene therapy, which goes beyond the conventional approach of single defective gene replacement, aims to provide ext...
About Spur Therapeutics
Freeline is a biopharmaceutical company focused on developing liver-directed gene therapies for inherited systemic diseases. With clinical programs for Hemophilia B and Fabry disease, and preclinical programs in Gaucher disease and haemophilia A, the company aims to revolutionize treatment options f...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Eikonoklastes Therapeutics, Inc. and Spur Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Eikonoklastes Therapeutics, Inc. or Spur Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Eikonoklastes Therapeutics, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Eikonoklastes Therapeutics, Inc. on 11 Sep 2024, and Spur Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
